Despite challenges, new advances in stem cell biology and genetic engineering show potential for better cell replacement therapies, say experts in a special supplement to JPD
Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson’s disease (PD) in future. Writing in an open access special supplement to the Journal of Parkinson’s Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great promise, as well as the significant challenges, of stem cell treatment.
The most common PD treatment today is based on enhancing the activity of the nigro-striatal pathway in the brain with dopamine-modulating therapies, thereby increasing striatal dopamine levels and improving motor impairment associated with the disease. However, this treatment has significant long-term limitations and side effects. Stem cell technologies show promise for treating PD and may play an increasing role in alleviating at least the motor symptoms, if not others, in the decades to come.
“We are in desperate need of a better way of helping people with PD. It is on the increase worldwide. There is still no cure, and medications only go part way to fully treat incoordination and movement problems,” explained co-authors Claire Henchcliffe, MD, DPhil, from the Department of Neurology, Weill Cornell Medical College, and Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; and Malin Parmar, PhD, from the Wallenberg Neuroscience Center and Lund Stem Cell Center, Lund University, Lund, Sweden. “If successful, using stem cells as a source of transplantable dopamine-producing nerve cells could revolutionize care of the PD patient in the future. A single surgery could potentially provide a transplant that would last throughout a patient’s lifespan, reducing or altogether avoiding the need for dopamine-based medications.”
The authors have analyzed how newly developed stem cell technologies could be used to treat PD, and how clinical researchers are moving very quickly to translate this technology to early clinical trials. In the past, most transplantation studies in PD used human cells from aborted embryos. While these transplants could survive and function for many years, there were scientific and ethical issues: fetal cells are in limited supply, and they are highly variable and hard to quality control. Only some patients benefited, and some developed side effects from the grafts, such as uncontrollable movements called dyskinesias.
Recent strides in stem cell technology mean that quality, consistency, activity, and safety can be assured, and that it is possible to grow essentially unlimited amounts of dopamine-producing nerve cells in the laboratory for transplantation. This approach is now rapidly moving into initial testing in clinical trials. The choice of starting material has also expanded with the availability of multiple human embryonic stem cell lines, as well as the possibilities for producing induced pluripotent cells, or neuronal cells from a patient’s own blood or skin cells. The first systematic clinical transplantation trials using pluripotent stem cells as donor tissue were initiated in Japan in 2018.
“We are moving into a very exciting era for stem cell therapy,” commented Dr. Parmar. “The first-generation cells are now being trialed and new advances in stem cell biology and genetic engineering promise even better cells and therapies in the future. There is a long road ahead in demonstrating how well stem cell-based reparative therapies will work, and much to understand about what, where, and how to deliver the cells, and to whom. But the massive strides in technology over recent years make it tempting to speculate that cell replacement may play an increasing role in alleviating at least the motor symptoms, if not others, in the decades to come.”
“With several research groups, including our own centers, quickly moving towards testing of stem cell therapies for PD, there is not only a drive to improve what is possible for our patients, but also a realization that our best chance is harmonizing efforts across groups,” added Dr. Henchcliffe. “Right now, we are just talking about the first logical step in using cell therapies in PD. Importantly, it could open the way to being able to engineer the cells to provide superior treatment, possibly using different types of cells to treat different symptoms of PD like movement problems and memory loss.”
“This approach to brain repair in PD definitely has major potential, and the coming two decades might also see even greater advances in stem cell engineering with stem cells that are tailor-made for specific patients or patient groups,” commented Patrik Brundin, MD, PhD, Van Andel Research Institute, Grand Rapids, MI, USA, and J. William Langston, MD, Stanford Udall Center, Department of Pathology, Stanford University, Palo Alto, CA, USA, Editors-in-Chief of the Journal of Parkinson’s Disease. “At the same time, there are several biological, practical, and commercial hurdles that need circumventing for this to become a routine therapy.”
The Latest on: Stem cell technologies
[google_news title=”” keyword=”stem cell technologies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell technologies
- STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Companyon February 29, 2024 at 1:43 pm
Major asset acquisition from a U.S.-based company marks another milestone for Canada’s largest biotechnology company VANCOUVER, British Columbia, February 29, 2024--(BUSINESS WIRE)--STEMCELL ...
- Stem cells meet AIon February 29, 2024 at 7:48 am
Somite was founded on the basis of years of work by one of the most prominent teams of scientists in the stem cell field, some of them Israeli. Breakstone's first connection to this group was through ...
- Would you save your child’s baby teeth? Doctors say it may aid in future STEM cell treatmenton February 29, 2024 at 6:31 am
Thanks to advancements in technology, STEM cells can now be extracted from a child’s tooth after it naturally falls out, offering a promising avenue for future medical interventions. For several years ...
- StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcaston February 29, 2024 at 6:01 am
I developed regenerative medicine systems with stem cell technology in the 1980's working on umbilical cord therapy to treat genetic diseases, cancers, and inherited disorders. In this manner I began ...
- JAIN University offers Premier BSc Nuclear Medicine and MSc Molecular Medicine & Stem Cell Technology programson February 28, 2024 at 11:02 pm
In a world where healthcare innovation is paramount, JAIN (Deemed-to-be University)'s School of Allied Health Sciences (SAHS) stands at the forefront, offering pioneering programs in Nuclear Medicine ...
- Dubai Stem Cell Congress concludes, offering new hope to cancer, diabetes patientson February 28, 2024 at 3:18 am
stem cell technologies, and innovative applications. What distinguishes the events of the second day of the conference are the impactful moments and survival stories shared by patients who recovered ...
- Stealthy stem cells to treat diseaseon February 27, 2024 at 4:00 pm
And both Vertex (which acquired ViaCyte in 2022, but is now working on separate stem-cell-derived therapies, using gene-editing technologies from CRISPR Therapeutics) and CRISPR Therapeutics (which ...
- Revolutionary stem cell culture method produces full model of human central nervous systemon February 26, 2024 at 11:14 am
The first stem cell culture method that produces a full model of the early stages of the human central nervous system has been developed by a team of engineers and biologists at the University of ...
- Dubai Stem Cell Congress begins featuring 30 International Speakerson February 26, 2024 at 8:01 am
The second edition of the Dubai Stem Cell Congress (DSCC) kicks off today at Palazzo Versace in Dubai.Its current edition brings together more than 30 experts and specialists in stem cell treatment ...
- Dubai Stem Cell Congress opens its doors to publicon February 26, 2024 at 7:23 am
stem cell technologies, and innovative applications. Emirates District Cooling (Emicool), a leading district cooling service provider in the region and a wholly owned subsidiary of Dubai Investments, ...
via Bing News